Advertisement
ResearchIn-Press PreviewGastroenterologyOncology
Open Access |
10.1172/JCI204312
1Department of Molecular Diagnostics and Experimental Therapeutics, Biomedical Research Center, Monrovia, United States of America
2Department of Clinical Laboratory, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3Department of Surgery, Medical College of Wisconsin, Milwaukee, United States of America
4Department of Systems Biology, The Beckman Research Institute of City of Hope, Monrovia, United States of America
Find articles by Zhu, J. in: PubMed | Google Scholar
1Department of Molecular Diagnostics and Experimental Therapeutics, Biomedical Research Center, Monrovia, United States of America
2Department of Clinical Laboratory, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3Department of Surgery, Medical College of Wisconsin, Milwaukee, United States of America
4Department of Systems Biology, The Beckman Research Institute of City of Hope, Monrovia, United States of America
Find articles by Zhang, Q. in: PubMed | Google Scholar
1Department of Molecular Diagnostics and Experimental Therapeutics, Biomedical Research Center, Monrovia, United States of America
2Department of Clinical Laboratory, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3Department of Surgery, Medical College of Wisconsin, Milwaukee, United States of America
4Department of Systems Biology, The Beckman Research Institute of City of Hope, Monrovia, United States of America
Find articles by Evans, D. in: PubMed | Google Scholar
1Department of Molecular Diagnostics and Experimental Therapeutics, Biomedical Research Center, Monrovia, United States of America
2Department of Clinical Laboratory, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3Department of Surgery, Medical College of Wisconsin, Milwaukee, United States of America
4Department of Systems Biology, The Beckman Research Institute of City of Hope, Monrovia, United States of America
Find articles by Su, R. in: PubMed | Google Scholar
1Department of Molecular Diagnostics and Experimental Therapeutics, Biomedical Research Center, Monrovia, United States of America
2Department of Clinical Laboratory, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3Department of Surgery, Medical College of Wisconsin, Milwaukee, United States of America
4Department of Systems Biology, The Beckman Research Institute of City of Hope, Monrovia, United States of America
Find articles by Pan, Q. in: PubMed | Google Scholar
1Department of Molecular Diagnostics and Experimental Therapeutics, Biomedical Research Center, Monrovia, United States of America
2Department of Clinical Laboratory, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3Department of Surgery, Medical College of Wisconsin, Milwaukee, United States of America
4Department of Systems Biology, The Beckman Research Institute of City of Hope, Monrovia, United States of America
Find articles by
Goel, A.
in:
PubMed
|
Google Scholar
|
Published August 11, 2026 - More info
Transfer RNA (tRNA) modifications play a critical role in regulating codon-specific mRNA translation and enabling tumor cell adaptation. The RNA methyltransferase METTL1 installs N7-methylguanosine (m⁷G) modifications on tRNAs, thereby shaping codon usage and translational output. However, the function and mechanistic contribution of the METTL1–tRNA axis in pancreatic ductal adenocarcinoma (PDAC) remain poorly defined. Here, we show that METTL1 is overexpressed in PDAC tissues and that elevated METTL1 expression is associated with poor patient survival. Genetic ablation of METTL1 markedly suppresses PDAC cell proliferation, migration, and tumor growth in vitro and in vivo. Mechanistically, METTL1 loss selectively reduces m⁷G-modified valine tRNAs – particularly, Val-AAC, Val-CAC, and Val-TAC – leading to impaired translation of valine-enriched oxidative phosphorylation transcripts. As a consequence, METTL1 deficiency disrupts mitochondrial respiration and energy production in PDAC cells. Consistent with this model, valine tRNA levels are elevated in PDAC tissues, and their selective depletion phenocopies METTL1 loss by impairing mitochondrial bioenergetics and tumor cell fitness. Thus, the METTL1–valine tRNA axis promotes PDAC progression through codon-dependent translational control of mitochondrial electron transport chain and oxidative metabolism. Together, our findings identify a METTL1–tRNA–mitochondrial signaling axis as a previously unrecognized metabolic vulnerability and a promising therapeutic target in pancreatic cancer.